X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 3 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding X4 Pharmaceuticals, Inc changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 99 | 2 | 98 | +1 |
| Shares | 101.5M | 10.7M | 100.6M | +9.73M (+10.7%) |
| Value | $58.9M | $6.20M | $67.3M | +$14.6M (+27.7%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 11,210,671 | $7.50M | 0.00% |
| Gsa Capital Partners LLP | 507,694 | $340.0K | 0.03% |
| AJOVista, LLC | 257,644 | $172.4K | 0.74% |
| Amundi | 81,305 | $44.0K | 0.00% |
| SG Americas Securities, LLC | 55,004 | $37.0K | 0.00% |
| Verition Fund Management LLC | 44,355 | $29.7K | 0.00% |
| TD Waterhouse Canada Inc. | 45,000 | $28.6K | 0.00% |
| Bayesian Capital Management, LP | 38,400 | $25.7K | 0.00% |
| Two Sigma Securities, LLC | 12,093 | $8.09K | 0.00% |
| Capital Performance Advisors LLP | 760 | $509 | 0.00% |
| True Wealth Design, LLC | 486 | $326 | 0.00% |
| Sterling Capital Management LLC | 172 | $115 | 0.00% |
Sold out (11)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Soleus Capital Management, L.P. | 4,051,000 | $2.35M |
| Velan Capital Investment Management LP | 659,020 | $382.2K |
| Hudson Bay Capital Management LP | 227,246 | $131.8K |
| Virtu Financial LLC | 50,537 | $29.0K |
| Holistic Planning, LLC | 13,800 | $19.2K |
| Resources Investment Advisors, LLC. | 21,500 | $12.5K |
| Allred Capital Management, LLC | 12,800 | $7.42K |
| Jump Financial, LLC | 10,362 | $6.01K |
| Citadel Advisors LLC | 8,413 | $4.88K |
| Russell Investments Group, Ltd. | 1,901 | $1.10K |
| Headlands Technologies LLC | 16 | $9 |
Not filed for Q3 2024 yet (2)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 10,675,963 | $6.19M |
| ICA Group Wealth Management, LLC | 6,400 | $3.71K |